For a very good reason many are not confident and the deal(s)...

For a very good reason many are not confident and the deal(s) have not been sold very well to SH. One would think a company would have to back up transactions with evidence and confirmation from customers other than just a handshake. Looking at MGC Pharmaceutical's time line there has been more talk than action. Finally they have admitted they are only going to focus on active deals as from now on.

There are 2 very important paragraphs that have come to our attention which has give us confidence with MGC statements below.

(a) The Board and Executive team completed a strategic review during the first half of 2018 on a number of
project initiatives and partnership opportunities that the Company had investigated or entered over the past
3 years. The Board wanted to rationalise and prioritise the Company’s resources and funds moving forward
and close all non-core initiatives. This resulted in the termination of all the non-material projects and
partnerships that the Company has been involved with since 2015.

(b) Management continues to focus its team and resources into the development of MXC’s European operations
to develop pharmaceutical grade medicines, and has a clear strategy for commercialisation to target the
strong growth in demand for medicinal cannabis products across Europe.